Design and Synthesis of Novel Trifunctional Drug Carrier Comprising Luminescent-Magnetic Nanocomposite Adorned with a pH-Sensitive Copolymer as a Controlled Switch for Dual Drug Delivery
Marjan Ghazimoradi,Aliakbar Tarlani,Abdolali Alemi,Marjan Ghorbani,Hamed Hamishehkar,Rajender S. Varma
DOI: https://doi.org/10.1016/j.jallcom.2024.173451
IF: 6.2
2024-01-28
Journal of Alloys and Compounds
Abstract:Since multifunctional nanomaterials have exhibited significant ability as carriers in biomedical applications, it is valuableto create such a drug delivery system for cancer treatment. In this context, a novel type of trifunctional nanocomposite (high magnetization (26.25 emu.g -1 ) and size about 24 nm)) with pH-responsive, luminescent and magnetic properties (NaCeF 4 :Yb/Er@SiO 2 @Fe 3 O 4 -NH 2 @poly(MAA-co-IA)), has been designed as a new platformfor efficient loading and the pH-responsive concurrent release of methotrexate (MTX) and doxorubicin (DOX). The luminescent and hollow NaCeF 4 :Yb/Er as a core is more suitable for deep-tissue diagnosis while Fe 3 O 4 in outer shell (instead of core) caused its magnetic property retain in comparison with other core shell drug nanocarriers. MTX and DOX were loaded into nanocarrier, the loading capacity being 35 and 99%, respectively) The structure and morphology of the prepared nanocarrier were characterized by XRD, FT‐IR, VSM, TEM, FE-SEM, PL, EDAX, DLS and Zeta potential analyses. The in vitro release studies at different pH values (7.4 and 5) exhibited the pH-responsivesystem. The biocompatibility of the drug free nanocarrier and the cytotoxicity of DOX, MTX, the mixture of drugs (MTX@DOX) and MTX@DOX-nanocarrier were investigated in different concentration (0.01 to 100 μg/mL) by MTT test on human breast epithelial adenocarcinoma (MDA-MB-231) cell line. The anti-cancer studies of the nanocarrier exhibited very low cytotoxicity and high cell viability (70%) against MDA-MB-231 cell line after 72 h. In vitro cytotoxicity tests of the MTX@DOX-nanocarrier against MDA-MB-231 cell line revealed low cell viability (11%) after 72 h. Cellular uptake depicted notably higher uptake percentage for DOX-NPs than free DOX within 3 h while DAPI staining results demonstrated the higher apoptotic effects of drugs-loaded nanocarrier than free form of the drugs. Based on the enticingresults attained, the NaCeF 4 :Yb/Er@SiO 2 @Fe 3 O 4 -NH 2 @poly(MAA-co-IA) nanocomposite could be used as a pH-sensitive and non-toxic carrier for the targeted therapy of aggressive MDA-MB-231 breast cancer cells and is suitable for controlled drug release and monitoring drug delivery.
materials science, multidisciplinary,chemistry, physical,metallurgy & metallurgical engineering